Structure | Compound Name | Standard Type | Standard Values (in nM) |
|---|---|---|---|
| Cilengitide | IC50 | 7.6 [1], 37.0 [2], 400.0 [3], 5400.0 [4] | |
| Cyclo(Arg-Gly-Asp-D-Phe-Val) | IC50 | 0.11 [1], 7.5 [2] | |
| 2-[(9S)-14-[3-(Pyridin-2-ylamino)propoxy]-9-tricyclo[9.4.0.03,8]pentadeca-1(11),3,5,7,12,14-hexaenyl]acetic acid | IC50 | 2.9 [1] | |
| 2-[(9S)-14-[3-(Pyridin-2-ylamino)propoxy]-9-tricyclo[9.4.0.03,8]pentadeca-1(11),3,5,7,12,14-hexaenyl]acetic acid | Ki | 1.3 [1], 2.6 [2] | |
| 3-[[5-[(2-Pyridyl)amino]pentanoylamino]acetylamino]-3-(4-biphenylyl)propionic acid | IC50 | 2670.0 [1], 26000.0 [2] | |
MLA | "Quest Database™ Integrin alpha-V/beta-5 Inhibitors (IC50, Ki)." AAT Bioquest, Inc., 7 Feb. 2026, https://www.aatbio.com/data-sets/integrin-alpha-v-beta-5-inhibitors-ic50-ki. | |
APA | AAT Bioquest, Inc. (2026, February 7). Quest Database™ Integrin alpha-V/beta-5 Inhibitors (IC50, Ki). AAT Bioquest. https://www.aatbio.com/data-sets/integrin-alpha-v-beta-5-inhibitors-ic50-ki. | |
| BibTeX | EndNote | RefMan |